99 related articles for article (PubMed ID: 2347709)
21. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
22. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
23. [A case of massive fatal hemorrhage in a recurrent medulloblastoma during radiotherapy].
Sugawara T; Shingai J; Ogawa A; Wada T; Suzuki J; Namiki T
No Shinkei Geka; 1986 Jan; 14(1):109-13. PubMed ID: 3081823
[TBL] [Abstract][Full Text] [Related]
24. Low-dose craniospinal radiation therapy for medulloblastoma.
Halberg FE; Wara WM; Fippin LF; Edwards MS; Levin VA; Davis RL; Prados MB; Wilson CB
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):651-4. PubMed ID: 2004939
[TBL] [Abstract][Full Text] [Related]
25. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
Paulino AC
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
[TBL] [Abstract][Full Text] [Related]
26. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
27. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
28. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma.
Johnson SB; Hung J; Kapadia N; Oh KS; Kim M; Hamstra DA
Pract Radiat Oncol; 2019 Jan; 9(1):e22-e28. PubMed ID: 30036592
[TBL] [Abstract][Full Text] [Related]
29. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of ependymomas by site of origin.
Marks JE; Adler SJ
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):37-43. PubMed ID: 7061255
[TBL] [Abstract][Full Text] [Related]
31. [Results of radiotherapy for medulloblastoma].
Gose K; Imajo Y; Imanaka K; Ichiyanagi A; Takashima H; Kimura S; Ogawa Y; Korosue K; Nogaki H; Tawamoto K
Rinsho Hoshasen; 1983 Aug; 28(8):871-5. PubMed ID: 6655943
[No Abstract] [Full Text] [Related]
32. Medulloblastoma: long-term follow-up of patients treated with electron irradiation of the spinal field.
Gaspar LE; Dawson DJ; Tilley-Gulliford SA; Banerjee P
Radiology; 1991 Sep; 180(3):867-70. PubMed ID: 1871308
[TBL] [Abstract][Full Text] [Related]
33. The natural history of stroke in sickle cell disease.
Powars D; Wilson B; Imbus C; Pegelow C; Allen J
Am J Med; 1978 Sep; 65(3):461-71. PubMed ID: 717414
[No Abstract] [Full Text] [Related]
34. Multiple cavernous angiomas after high-dose whole-brain radiation therapy.
Novelli PM; Reigel DH; Langham Gleason P; Yunis E
Pediatr Neurosurg; 1997 Jun; 26(6):322-5. PubMed ID: 9485161
[TBL] [Abstract][Full Text] [Related]
35. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
36. Growth and endocrine function after treatment for medulloblastoma.
Brown IH; Lee TJ; Eden OB; Bullimore JA; Savage DC
Arch Dis Child; 1983 Sep; 58(9):722-7. PubMed ID: 6414386
[TBL] [Abstract][Full Text] [Related]
37. The change in patterns of relapse in medulloblastoma.
Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
[TBL] [Abstract][Full Text] [Related]
38. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
[TBL] [Abstract][Full Text] [Related]
39. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.
Gajjar A; Mulhern RK; Heideman RL; Sanford RA; Douglass EC; Kovnar EH; Langston JA; Jenkins JJ; Kun LE
J Clin Oncol; 1994 Jun; 12(6):1212-6. PubMed ID: 8201384
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
